While Align Technology, Inc has underperformed by -1.64%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ALGN fell by -34.23%, with highs and lows ranging from $246.19 to $122.00, whereas the simple moving average fell by -16.85% in the last 200 days.
On October 10, 2025, Jefferies Downgraded Align Technology, Inc (NASDAQ: ALGN) to Hold. A report published by Morgan Stanley on July 31, 2025, Downgraded its rating to ‘Equal-Weight’ for ALGN. HSBC Securities also Downgraded ALGN shares as ‘Hold’, setting a target price of $170 on the company’s shares in a report dated April 25, 2025. Wells Fargo Initiated an Overweight rating on February 14, 2025, and assigned a price target of $255. Leerink Partners January 06, 2025d its ‘Market Perform’ rating to ‘Outperform’ for ALGN, as published in its report on January 06, 2025. Mizuho’s report from December 04, 2024 suggests a price prediction of $295 for ALGN shares, giving the stock a ‘Outperform’ rating. Needham also rated the stock as ‘Hold’.
Analysis of Align Technology, Inc (ALGN)
Further, the quarter-over-quarter increase in sales is 1.82%, showing a positive trend in the upcoming months.
One of the most important indicators of Align Technology, Inc’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of 9.58% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 1.17, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and ALGN is recording 1.27M average volume. On a monthly basis, the volatility of the stock is set at 3.32%, whereas on a weekly basis, it is put at 3.21%, with a gain of 1.70% over the past seven days. Furthermore, long-term investors anticipate a median target price of $174.92, showing growth from the present price of $137.13, which can serve as yet another indication of whether ALGN is worth investing in or should be passed over.
How Do You Analyze Align Technology, Inc Shares?
The Medical Instruments & Supplies market is dominated by Align Technology, Inc (ALGN) based in the USA. When comparing Align Technology, Inc shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 26.57, there is a growth in quarterly earnings of -49.48%.
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 6.55%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 97.23% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
